Power Law company profile

AbSci

Biotech & Life Sciences · Vancouver, United States · Founded 2011 · IPO 2021 Unicorn

The global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry

Valuation

$635M

Market cap · May/2026

Revenue

$2.8M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

17 investors on AbSci's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Phoenix Venture Partners

Series B+ 16 investors entered at this stage

D1 Capital Partners

JSR Corporation

Redmile Group

Greenbridge Partners

AGC

Irving Investors

ArrowMark Partners

Perceptive Advisors

Fidelity Investments

KBI Biopharma

JSR Life Sciences

Columbia Ventures Corporation

Oregon Entrepreneurs Network

Casdin Capital

WRF Capital

Merck Global Health Innovation Fund

Global footprint

Where AbSci has talent and traffic

AI talent share

10.3% of workforce is AI talent
(18 of 175 staff)

Core AI137.43%

Other AI52.86%

Non-AI workforce15789.71%

Workforce by country

8 countries with
team presence

🇺🇸 United States88.3%

🇷🇸 Serbia4.2%

🇨🇭 Switzerland3.3%

🇬🇧 United Kingdom1.4%

🏳️ Côte d'Ivoire0.7%

Top 5 of 8 shown

Web traffic by country

21K monthly visits
across markets

🇺🇸 United States35.7%

🇦🇺 Australia15.2%

🇨🇦 Canada13.8%

🏳️ Korea8.1%

🏳️ Republic of7.6%

Top 5 markets shown

Patent intelligence

$17M patent portfolio · 32 active families

Estimated portfolio value

$17M

2.7% of market cap · 118.4× smaller than top peer Ablynx ($2B)

32 active patent families

Where AbSci innovates Molecular biologyBiological organismNucleic acidProteinCell biology

Where AbSci concentrates vs peers

Each axis is a top-10 topic across AbSci and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about AbSci

An AI-synthesized read of the highest-engagement posts about AbSci on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AbSci on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles